Rita Jain - Jan 7, 2025 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role: Director
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Stock symbol: ANAB
Transactions as of: Jan 7, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/7/2025, 05:30 PM
Previous filing: Jun 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANAB	Stock Option (right to buy)	Award	$0	+16.5K		$0.00	16.5K	Jan 7, 2025	Common Stock	16.5K	$14.83	Direct	F1
transaction	ANAB	Restricted Stock Unit	Award	$0	+6.03K		$0.00	6.03K	Jan 7, 2025	Common Stock	6.03K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2	Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F3	The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.